Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors
about
Therapeutic Use of Native and Recombinant EnterovirusesHIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesChallenges in mucosal HIV vaccine development: lessons from non-human primate modelsObstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.Development of replication-competent viral vectors for HIV vaccine delivery.Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGNInduction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vectorA single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.New hope for an AIDS vaccine.Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinantsMucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties.Perils at mucosal front lines for HIV and SIV and their hosts.Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates.Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery.A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Use of viral vectors for the development of vaccines.Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge.Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS.Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route.Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.Human Rhinovirus-A1 as an Expression Vector.Emergency Services of Viral RNAs: Repair and Remodeling.
P2860
Q26767082-1501D263-2A76-4494-9410-EA53374E01E9Q26799624-F155920C-7946-4CF0-A910-38C4222AFA7AQ27022152-3F5B7357-3104-4B0F-B182-2F1D1EED9366Q30378897-528464FB-30FB-4988-B167-C28BFA050F3DQ30381447-A37CC4BB-A549-46D2-8FC4-62837C93743EQ33686890-B6B01726-C42F-49F0-A1C0-25583F4BCACDQ33694226-EB2D0483-DB16-4F60-BD48-D46A16D812C2Q34010226-BC86AA17-1F23-4041-B3A1-5CFA715F0968Q34333402-500305CD-0117-4BC2-8539-500B79C29123Q34356433-3F2E4969-22CE-4346-BC18-552F3535594FQ34552313-BB05038A-BE12-4D37-88BE-76D079E144D9Q34632063-6ECF5C46-5EB7-4862-AAE5-0511A63BE979Q34651604-673076CF-BACB-474C-8DDE-EC3D21A0AB7EQ35182076-DF636B16-B90F-4ED7-8224-F5B09037816CQ35973518-46BE249F-AF4D-4CFB-9C56-0EEB3F8A7ADDQ36209689-ECDEF86D-9E89-4DC6-A809-6918FA1970DCQ36274922-310BD609-0DA6-4D42-9532-A3B8896FAF6CQ36510009-CF04D23B-2CFD-4062-959C-0189AD1D74CBQ36539997-9BA9EA58-5990-4F6C-ADEB-B86E9C742A71Q36541009-7892DDCC-44FE-4C86-A044-CC6CD2C1C572Q36780136-F5FA99AC-2235-4980-AFE9-53AD77D2DDF5Q36780156-C458EDE1-C71D-4A9C-B5E0-F7A73A3EEC7CQ36954239-52C0242E-6299-4B8D-9472-5D9C8BD0EFA3Q37067177-B41D9E70-5840-42E6-BED7-77FF47AE603EQ37257457-226FD30E-6277-4183-B1BA-6328DCDF41C7Q37297052-02578E00-B728-4ADC-A571-B176BA17F8D9Q37340465-F0F8559B-9BF8-48CD-AD05-010638D5CE5BQ37348513-225B7E91-1ABB-4858-923A-4B98EEF9A686Q37349966-BAEAB624-8464-45BD-9E83-08AA65D682F5Q37419985-D4ECE35B-B967-4906-8122-94393550B10EQ39197846-78FC936E-3A93-40AB-BB3D-7ECCB77B50D4Q39699309-1E7AE037-B623-47D1-842B-FC866C270B5BQ40259597-439DD4B0-0CCD-41D6-A902-618214CD1698Q52655516-3CF1298C-7256-4C9E-AD0E-46BA10A2225C
P2860
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protection against simian immu ...... using Sabin poliovirus vectors
@ast
Protection against simian immu ...... using Sabin poliovirus vectors
@en
type
label
Protection against simian immu ...... using Sabin poliovirus vectors
@ast
Protection against simian immu ...... using Sabin poliovirus vectors
@en
prefLabel
Protection against simian immu ...... using Sabin poliovirus vectors
@ast
Protection against simian immu ...... using Sabin poliovirus vectors
@en
P2093
P2860
P1433
P1476
Protection against simian immu ...... using Sabin poliovirus vectors
@en
P2093
B L Lohman
C J Miller
J D Lifson
P2860
P304
P356
10.1128/JVI.75.16.7435-7452.2001
P577
2001-08-01T00:00:00Z